InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Requadt Scott, 董事长兼首席执行官. Director active across 2 companies, notably Talaris Therapeutics, Inc.. Aggregated, 9 reports have been recorded. Split: 3 buys · 0 sell. Total volume traded: €222k. Activity tracked since 31 December 2021. The latest transaction was disclosed on 30 October 2023 (J). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Requadt Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
30,002 股Common SharesSEC:0001104659-25-099650:0
17,502 股0Common SharesSEC:0001209191-24-001597:0
11,786 股@ US$3.0811.5% 占其流量Common StockSEC:0001209191-23-041610:0
4 股@ US$0.8670.0% 占其流量Common StockSEC:0001209191-23-006998:0
80,000 股0Common StockSEC:0000899243-22-030931:0
39,382 股@ US$4.2556.8% 占其流量Common StockSEC:0000899243-22-027404:0
标准退出：2022年10月27日 (T+90)
5,528 股@ US$4.248.0% 占其流量Common StockSEC:0000899243-22-026986:0
标准退出：2022年10月24日 (T+90)
9,444 股@ US$3.749712.0% 占其流量Common StockSEC:0000899243-22-026759:0
标准退出：2022年10月20日 (T+90)
1,470 股@ US$13.006.2% 占其流量Common StockSEC:0000899243-22-004202:0
9 条申报中的 9 条
About Requadt Scott
Requadt Scott is President and Chief Executive Officer and is associated with Talaris Therapeutics, Inc. and ESSA Pharma Inc., where he is a Director. The record shows 9 filings in total, and across the 9 sampled filings the activity consists of attributions with EUR 222000 of buys and EUR 0 of sells between 2022-02-02 and 2025-10-15.
